evidence: References - Hobbs CV, Woodworth K, Young CC, et al.; Overcoming COVID-19 Investigators. Frequency, characteristics and complications of COVID-19 in hospitalized infants. Pediatr Infect Dis J 2022;41:e81–6. https://doi.org/10.1097/INF.0000000000003435 PMID:34955519 - Marchant A, Sadarangani M, Garand M, et al. Maternal immunisation: collaborating with mother nature. Lancet Infect Dis 2017;17:e197–208. https://doi.org/10.1016/S1473-3099(17)30229-3 PMID:28433705 - Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy. Am J Obstet Gynecol MFM 2022;4:100492. https://doi.org/10.1016/j.ajogmf.2021.100492 PMID:34547533 - Trostle ME, Aguero-Rosenfeld ME, Roman AS, Lighter JL. High antibody levels in cord blood from pregnant women vaccinated against COVID-19. Am J Obstet Gynecol MFM 2021;3:100481. https://doi.org/10.1016/j.ajogmf.2021.100481 PMID:34562636 - Yang YJ, Murphy EA, Singh S, et al. Association of gestational age at coronavirus disease 2019 (COVID-19) vaccination, history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a vaccine booster dose with maternal and umbilical cord antibody levels at delivery. Obstet Gynecol 2021. Epub December 28, 2021. https://doi.org/10.1097/AOG.0000000000004693 PMID:34963127 - Olson SM, Newhams MM, Halasa NB, et al.; Overcoming Covid-19 Investigators. Effectiveness of BNT162b2 vaccine against critical Covid-19 in adolescents.